Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
clinical trials
life sciences
migraine
3
×
national blog main
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
bausch health
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
dihydroergotamine
eli lilly
fremanezumab
glaxosmithkline
impel neuropharma
indiana blog main
indiana top stories
medical device
multiple myeloma
national
national top stories
san diego blog main
san diego top stories
satsuma pharmaceuticals
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
What
companies
3
×
drug
3
×
approval
migraine
new
activity
arguments
big
bio
biogen’s
biopharmaceutical
biotech
class
commercialized
competitors
convo
days
decades
dog
drugs
earlier
failures
fda
firm
hasn’t
ipo
ipos
leading
line
littered
make
meeting
nash
neuro
news
oral
pfizer
place
potential
prep
Language
unset
Current search:
biotech
×
companies
×
drug
×
migraine
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More